Profile data is unavailable for this security.
About the company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
- Revenue in USD (TTM)3.97bn
- Net income in USD515.10m
- Incorporated1990
- Employees6.99k
- LocationHologic Inc250 Campus DriveMARLBOROUGH 1752United StatesUSA
- Phone+1 (508) 263-2900
- Fax+1 (302) 655-5049
- Websitehttps://www.hologic.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teleflex Inc | 2.97bn | 357.57m | 9.92bn | 14.50k | 27.87 | 2.23 | 16.55 | 3.34 | 7.56 | 7.53 | 62.88 | 94.41 | 0.4114 | 2.20 | 6.98 | 205,137.20 | 4.95 | 5.86 | 5.39 | 6.42 | 55.37 | 55.04 | 12.02 | 14.62 | 1.29 | 7.78 | 0.2901 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Insulet Corp | 1.70bn | 206.30m | 12.18bn | 3.00k | 61.72 | 16.60 | 43.64 | 7.18 | 2.82 | 2.82 | 22.78 | 10.48 | 0.7014 | 1.43 | 6.00 | 565,700.00 | 8.53 | 2.71 | 10.26 | 3.14 | 68.35 | 65.81 | 12.16 | 4.28 | 2.62 | 40.74 | 0.659 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Shockwave Medical Inc | 730.23m | 147.28m | 12.27bn | 1.47k | 84.77 | 18.09 | 77.83 | 16.80 | 3.86 | 3.86 | 19.13 | 18.08 | 0.66 | 1.04 | 7.86 | 497,431.90 | 13.31 | 10.29 | 14.40 | 11.39 | 86.94 | 84.69 | 20.17 | 15.14 | 10.73 | 19.70 | 0.5226 | 0.00 | 49.11 | 126.45 | -31.81 | -- | 72.88 | -- |
| Hologic Inc | 3.97bn | 515.10m | 18.20bn | 6.99k | 36.86 | 3.91 | 21.64 | 4.59 | 2.10 | 2.10 | 16.13 | 19.84 | 0.447 | 2.70 | 5.90 | 567,854.10 | 5.80 | 11.40 | 6.48 | 13.38 | 55.44 | 60.29 | 12.98 | 20.95 | 3.18 | -- | 0.3565 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Cooper Companies Inc | 3.67bn | 290.80m | 18.29bn | 15.00k | 93.01 | 2.38 | 27.48 | 4.99 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Steris PLC | 5.41bn | 566.84m | 19.88bn | 17.00k | 35.48 | 3.10 | 17.42 | 3.68 | 5.67 | 5.67 | 54.18 | 64.93 | 0.4864 | 3.94 | 6.05 | 318,081.40 | 5.11 | 3.99 | 5.54 | 4.37 | 43.60 | 43.41 | 10.50 | 7.90 | 1.49 | 6.42 | 0.3399 | 49.05 | 8.13 | 13.61 | -56.12 | -17.02 | 16.95 | 8.74 |
| Baxter International Inc | 14.81bn | -76.00m | 20.39bn | 60.00k | -- | 2.42 | 17.08 | 1.38 | -0.1508 | 5.22 | 29.23 | 16.55 | 0.5238 | 3.43 | 5.48 | 246,883.30 | -0.244 | 0.1942 | -0.3054 | 0.2333 | 35.89 | 38.20 | -0.4658 | 0.3674 | 1.04 | 3.28 | 0.6197 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Align Technology, Inc. | 3.86bn | 445.05m | 22.93bn | 21.61k | 52.41 | 6.30 | 39.04 | 5.94 | 5.81 | 5.81 | 50.43 | 48.36 | 0.642 | 3.64 | 4.38 | 178,725.60 | 7.40 | 16.34 | 11.07 | 24.14 | 70.08 | 71.72 | 11.52 | 23.16 | 1.04 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Zimmer Biomet Holdings Inc | 7.39bn | 1.02bn | 25.48bn | 18.00k | 25.37 | 2.04 | 12.89 | 3.45 | 4.89 | 4.89 | 35.26 | 60.70 | 0.3475 | 0.9195 | 5.24 | 410,794.40 | 4.82 | 2.21 | 5.49 | 2.52 | 71.82 | 71.25 | 13.86 | 7.28 | 0.7784 | 7.32 | 0.316 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Resmed Inc | 4.50bn | 890.39m | 27.22bn | 10.14k | 30.66 | 6.07 | 25.41 | 6.04 | 6.04 | 6.04 | 30.53 | 30.47 | 0.6633 | 2.10 | 6.17 | 444,189.10 | 13.11 | 13.59 | 14.74 | 15.89 | 55.11 | 56.98 | 19.77 | 19.22 | 1.89 | 19.64 | 0.2149 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 26.65m | 11.35% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 22.07m | 9.40% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 14.93m | 6.36% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 11.10m | 4.73% |
| Geode Capital Management LLCas of 31 Dec 2023 | 5.58m | 2.38% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Dec 2023 | 5.06m | 2.15% |
| Macquarie Investment Management Business Trustas of 31 Dec 2023 | 4.24m | 1.81% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 4.02m | 1.71% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2023 | 3.43m | 1.46% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 3.21m | 1.37% |
